Scaling biology to replace the fossil age.
Inscripta, recently merged with Manus, enables scalable biomanufacturing and development of bioalternatives to fossil-based ingredients, materials, and chemicals through advanced gene editing technology.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.